125 related articles for article (PubMed ID: 11085959)
1. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction.
Mustafa A; Nityanand S; Berglund L; Lithell H; Lefvert AK
Circulation; 2000 Nov; 102(21):2576-81. PubMed ID: 11085959
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
[TBL] [Abstract][Full Text] [Related]
3. Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before age 45 years.
Lefvert AK; Hamsten A; Holm G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):665-8. PubMed ID: 7749879
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction.
Vallejo J; Dunér P; Fredrikson GN; Nilsson J; Bengtsson E
J Intern Med; 2017 Dec; 282(6):496-507. PubMed ID: 28944562
[TBL] [Abstract][Full Text] [Related]
5. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications.
Ahmed E; Nityanand S; Mustafa A; Brismar K; Lefvert AK
Clin Exp Immunol; 1999 Feb; 115(2):255-9. PubMed ID: 9933450
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes, immunoglobulin classes (IgG, IgA and IgM) and complement components (C3c, C4 and Factor B) in diabetic Nigerians.
Akinlade KS; Arinola OG; Salimonu LS; Oyeyinka GO
West Afr J Med; 2004; 23(3):253-5. PubMed ID: 15587841
[TBL] [Abstract][Full Text] [Related]
7. Gliadin IgG antibodies and circulating immune complexes.
Eisenmann A; Murr C; Fuchs D; Ledochowski M
Scand J Gastroenterol; 2009; 44(2):168-71. PubMed ID: 18819035
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes induced by food proteins implicated in precocious myocardial infarction.
Mustafa A; Hamsten A; Holm G; Lefvert AK
Ann Med; 2001 Mar; 33(2):103-12. PubMed ID: 11327113
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
[TBL] [Abstract][Full Text] [Related]
10. C4 null alleles and myocardial infarction.
Nityanand S; Hamsten A; Lithell H; Holm G; Lefvert AK
Atherosclerosis; 1999 Apr; 143(2):377-81. PubMed ID: 10217367
[TBL] [Abstract][Full Text] [Related]
11. Association of serum C3 levels with the risk of myocardial infarction.
Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
[TBL] [Abstract][Full Text] [Related]
12. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; Moritz T;
Atherosclerosis; 2012 Oct; 224(2):526-31. PubMed ID: 22963984
[TBL] [Abstract][Full Text] [Related]
13. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
14. Mannan-binding lectin may facilitate the clearance of circulating immune complexes--implications from a study on C2-deficient individuals.
Saevarsdottir S; Steinsson K; Ludviksson BR; Grondal G; Valdimarsson H
Clin Exp Immunol; 2007 May; 148(2):248-53. PubMed ID: 17335556
[TBL] [Abstract][Full Text] [Related]
15. Significance of Anti-Myosin Antibody Formation in Patients With Myocardial Infarction: A Prospective Observational Study.
O'Donohoe TJ; Schrale RG; Sikder S; Surve N; Rudd D; Ketheesan N
Heart Lung Circ; 2019 Apr; 28(4):583-590. PubMed ID: 29653839
[TBL] [Abstract][Full Text] [Related]
16. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.
Vaarala O; Mänttäri M; Manninen V; Tenkanen L; Puurunen M; Aho K; Palosuo T
Circulation; 1995 Jan; 91(1):23-7. PubMed ID: 7805207
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
18. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
[TBL] [Abstract][Full Text] [Related]
19. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program.
Brey RL; Abbott RD; Curb JD; Sharp DS; Ross GW; Stallworth CL; Kittner SJ
Stroke; 2001 Aug; 32(8):1701-6. PubMed ID: 11486093
[TBL] [Abstract][Full Text] [Related]
20. Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction.
Crisby M; Henareh L; Agewall S
Angiology; 2014 Nov; 65(10):932-6. PubMed ID: 24288363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
